Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?
NCT01772888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2020-03-24
Summary
Study aims: The primary aim is to determine whether chewing efficiency, determined by a two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.
Conditions
- Amyotrophic Lateral Sclerosis 11
Sponsors & Collaborators
-
University Hospital, Geneva
lead OTHER
Principal Investigators
-
Laurence Genton, MD · University Hospital, Geneva
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Ultra-high-caloric, Fatty Diet in ALS
NCT06280079 ·Status: RECRUITING ·Phase: NA
-
Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy
NCT00296621 ·Status: COMPLETED ·Phase: PHASE2
-
Delineating Swallowing Impairment and Decline in ALS
NCT02962050 ·Status: COMPLETED
-
Brown Adipose Tissue in ALS
NCT03150290 ·Status: COMPLETED ·Phase: NA
-
Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS)
NCT04454892 ·Status: RECRUITING
-
Safety Study of High Doses of Zinc in ALS Patients
NCT01259050 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tongue-strengthening Exercises in People With ALS.
NCT07295990 ·Status: RECRUITING ·Phase: NA
-
Metagenomic Characterization of the Intestinal Microbiota in ALS Patients and Association With Clinical Phenotypes
NCT06771414 ·Status: NOT_YET_RECRUITING
-
Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients With Amyotrophic Lateral Sclerosis
NCT06608004 ·Status: RECRUITING
-
Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis
NCT04518540 ·Status: UNKNOWN ·Phase: NA
-
Amyotrophic Lateral Sclerosis and the Innate Immune System
NCT02869048 ·Status: RECRUITING
-
Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis
NCT07170865 ·Status: NOT_YET_RECRUITING
-
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
NCT04882904 ·Status: RECRUITING ·Phase: NA
-
Effects of Gastrostomy on Amyotrophic Lateral Sclerosis
NCT00337402 ·Status: COMPLETED
-
Neuromuscular Ultrasound in ALS
NCT01785550 ·Status: COMPLETED
-
Evaluating the Potential of the Diet as Disease Modifier in Amyotrophic Lateral Sclerosis (JERN_ALS)
NCT02572479 ·Status: COMPLETED
-
Ability of Muscle Imaging and Motor Function Measure (MFM) to Detect Changes in Disease Progression in Ambulant Spinal Muscular Atrophy Patients Compared to Healthy Volunteers.
NCT02044029 ·Status: COMPLETED
-
Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
NCT02969759 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)
NCT02582385 ·Status: COMPLETED
-
Enoxacin for Amyotrophic Lateral Sclerosis (ALS)
NCT04840823 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
NCT02424669 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy
NCT06562283 ·Status: RECRUITING ·Phase: NA
-
High Fat/High Calorie Trial in Amyotrophic Lateral Sclerosis
NCT00983983 ·Status: COMPLETED ·Phase: PHASE2
-
Neurofilament Light Chain in Amyotrophic Lateral Sclerosis
NCT06201650 ·Status: RECRUITING
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00330681 ·Status: COMPLETED ·Phase: PHASE3